8-K: Livechain Acquires Humanyze Debt, Eyes National Exchange Uplisting

Livechain, a Vyome subsidiary, completed an all-stock acquisition of Humanyze's senior secured debt, positioning itself in the AI HR market and paving the way for a potential national exchange uplisting in 2026.

Summary

• Livechain, Inc. (LICH), a subsidiary of Vyome Holdings, Inc. (Vyome), acquired senior, secured convertible notes of Sociometric Solutions, Inc., d/b/a Humanyze (Humanyze) from Remus Capital Series B II, L.P. (Remus).
• The transaction was structured as an all-stock deal, with LICH issuing shares of its common stock valued at approximately $325,000 to Remus.
• The acquired notes had an aggregate principal amount of $5,765,000.
• LICH issued 211,200,844 shares of its common stock to Remus, representing 25% of LICH's fully diluted common stock immediately prior to the closing.
• Through this transaction, LICH initiated a default and asset transfer to assume all business assets, including intellectual property and trade secrets, and take direct control of Humanyze's daily operations.
• The acquisition transforms Livechain into the AI HR space and creates a path for a potential uplisting to a national exchange in 2026.
• Vyome, as the majority shareholder of Livechain, expects to benefit significantly from any value created by Livechain.
• Livechain plans to operate with its own team and capital, without using Vyome's capital or operational bandwidth.
• An additional 84,480,338 shares of LICH common stock (10% of fully diluted prior to closing) are reserved for issuance to key and future employees.
• Remus will receive additional LICH shares equal to 33.333% of any Compensatory Shares issued within two years, up to a maximum of 84,480,338 Compensatory Shares, to prevent dilution of its 25% ownership.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a strategically positive move, despite the underlying distress of the acquired entity. The entry into the high-growth AI HR market and the clear path towards a national exchange uplisting are strong indicators of future potential, though execution risks remain.

Positives

• Livechain's entry into the rapidly evolving AI HR space through the acquisition of Humanyze, an MIT-incubated, AI-enabled HR analytics company.
• The transaction creates a path for Livechain to seek potential uplisting to a national exchange in 2026.
• Potential for significant value creation for Livechain shareholders and, consequently, for Vyome Holdings, Inc. as the majority shareholder.
• Livechain will operate with its own team and capital, indicating a focused strategy and minimizing direct resource drain on Vyome.
• Humanyze's AI-enabled platform addresses human capital issues for Fortune 1000 companies, offering clear, actionable data for workplace improvements and bottom-line optimization.

Negatives

• The transaction involved initiating a default and asset transfer of Humanyze, suggesting Humanyze was in financial distress prior to the acquisition.
• Remus Capital, the seller of the debt, is required to ensure Humanyze remains active and in good standing for servicing select existing debts and liabilities for at least 24 months post-closing, and indemnifies LICH for related losses, indicating potential ongoing liabilities or complexities.
• The 'Outside Date' for closing the transaction was amended from February 20, 2026, to March 8, 2026, indicating a minor delay in the closing process.

Risks

• Forward-looking statements are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict and many of which are outside of the company's control.
• Actual results and financial condition may differ materially from those indicated in forward-looking statements.
• General economic conditions, conditions in securities, capital, credit, and currency markets, and industry-specific conditions could materially affect the business.
• Changes in law, regulatory conditions, GAAP, or other accounting standards could impact operations.
• Acts of terrorism, war, natural disasters, and other force majeure events could affect operations.
• Vyome's ability to raise capital to fund continuing operations.
• Ability to protect intellectual property rights.
• Impact of any infringement actions or other litigation.
• Competition from other providers and products.
• Ability to develop and commercialize products and services.
• Changes in government regulation.
• Ability to complete capital raising transactions.

Future Outlook

Livechain intends to pursue strategic alternatives in emerging technology sectors, specifically entering the artificial intelligence space through the acquisition of AI-driven assets focused on human capital, workforce intelligence, and human relationship management. The company also seeks to evaluate additional synergistic opportunities to build a scalable AI platform. A key objective is to create a path for uplisting to a national exchange in 2026, which is expected to generate significant value for shareholders.

Management Comments

• "First of all, this transaction transforms Livechain, driving it into an exciting and rapidly evolving AI HR space, creating a path for uplisting to a national exchange, and giving it the potential to generate real value for its shareholders." Krishna Gupta, Chairman of Vyome.
• "Second, the value creation under Livechain also has the potential to deliver real and lasting value to the shareholders of Vyome. As the majority shareholder of Livechain, Vyome stands to benefit significantly from any value created under Livechain. Our focus is on shareholder value, and our desire is that as Livechains underlying value increases, Vyome will be positioned to increase its Livechain equity position." Krishna Gupta, Chairman of Vyome.
• "Humanyze is attacking one of the biggest issues facing Fortune 1000 companies around the world – human capital, and the cost of developing, retaining, and rewarding people in the most cost-effective way possible, all of which is even more important in an AI-first world." Venkat Nelabhotla, CEO of Vyome and board member of Livechain.
• "We see multiple ways for Humanyze to create value and position Livechain for an uplisting to a national exchange. Livechain will have its own team and plans to have its own capital on a go-forward basis. We do not anticipate that Livechain will be using any capital or operational bandwidth of Vyome." Venkat Nelabhotla, CEO of Vyome and board member of Livechain.

Industry Context

StockSavvy.ai notes that the acquisition positions Livechain in the burgeoning AI-enabled Human Resources (HR) analytics market, a sector experiencing rapid growth as companies increasingly leverage data and artificial intelligence to optimize workforce management, talent retention, and operational efficiency. This strategic pivot aligns with broader industry trends emphasizing data-driven decision-making in HR, moving beyond traditional HR functions to predictive analytics and employee experience enhancement. Humanyze, originating from MIT Media Lab, brings a strong academic foundation and specialized AI capabilities, potentially offering Livechain a competitive edge in a market where innovation and proprietary technology are key differentiators. The focus on Fortune 1000 companies indicates an intent to target high-value enterprise clients, a segment with significant demand for sophisticated HR solutions.

Comparison to Industry Standards

• NA The filing does not provide specific comparable companies, projects, or results to assess against global benchmarks. The focus is on the strategic entry into the AI HR space and future potential rather than current performance metrics against industry peers.

Corporate Governance

Legal Proceedings

• Remus represented that there are no pending or threatened legal proceedings against Humanyze or its subsidiaries that would cause a Material Adverse Effect or challenge the transactions.
• No outstanding orders restrict or prohibit the ownership, use, operation, or disposition of any material asset of Humanyze.
• No actions pending or threatened involving alleged violations of applicable securities laws, antitrust, anti-corruption, sanctions, export control, environmental, or employment/labor laws that would reasonably be expected to have a Humanyze Material Adverse Effect.
• No stockholder actions pending or threatened relating to the Transactions, alleged breaches of fiduciary duty, or disclosure obligations that would result in material injunctive relief or damages.
• Neither Humanyze nor its subsidiaries have received written notice of formal investigation or enforcement proceedings, other than routine inquiries not expected to result in a Material Adverse Effect.

Related Party Transactions

• The Notes Purchase and Exchange Agreement is a related party transaction. Krishna K. Gupta, founder and CEO of Remus Capital, is also the Chairman of Vyome Holdings, Inc. (Livechain's parent company).
• John Tincoff, a partner of Remus, and Stash Pomichter, also a partner of Remus, are involved. Krishna K. Gupta and John Tincoff recused themselves from the Audit Committee's deliberations, and Krishna K. Gupta, Stash Pomichter, and John Tincoff recused themselves from the Board of Directors' deliberations regarding the Agreement.

Stakeholder Impact

• **Shareholders (Livechain & Vyome):** Potential for significant value creation through entry into the AI HR market and a path to national exchange uplisting. Vyome, as the majority shareholder of Livechain, stands to benefit directly.
• **Remus Capital:** Received 25% of Livechain's fully diluted common stock and protection against dilution from compensatory share issuances for two years.
• **Humanyze Employees:** Reservation of 10% of Livechain's fully diluted common stock for key and future employees, indicating potential retention and incentive for the acquired workforce.
• **Humanyze Creditors (other than Remus):** Remus is obligated to ensure Humanyze remains active and in good standing for servicing select existing debts and liabilities for at least 24 months, suggesting some protection for other creditors despite the asset transfer.

Next Steps

• Completion of the asset transfer of Humanyze's assets and operations to LICH AI Inc. immediately following the closing.
• LICH board and CEO to use commercially reasonable efforts to raise capital for LICH and/or LICH AI Inc. as needed.
• Livechain to evaluate additional synergistic opportunities to build a scalable AI platform.
• Livechain to pursue a potential uplisting to a national exchange in 2026.
• Remus to ensure Humanyze remains active and in good standing for servicing select existing debts, liabilities, and other obligations for at least 24 months after the effective date.

Key Dates

Recommendation

The acquisition represents a significant strategic pivot for Livechain into the high-growth AI HR sector, with clear intentions for a national exchange uplisting, which are strong positive catalysts. However, the transaction involves acquiring a company via default and asset transfer, implying prior financial distress for Humanyze. While the potential for value creation is high, the execution risk associated with integrating a distressed asset and achieving the uplisting remains. The company also explicitly states the need to raise capital. Given the mix of high potential and inherent risks, a 'hold' recommendation is appropriate for investors to monitor the integration, capital raising efforts, and progress towards uplisting before making further investment decisions.

Keywords

AI HR analytics, Human Capital Management, Workforce Intelligence, SEC Filing, Acquisition, Debt Purchase, Uplisting, Livechain, Vyome, Humanyze, Remus Capital, Convertible Note, Strategic Alternatives, Technology Sector